Dr. Michael Mina argues that Susan Monarez is the right choice to lead the CDC time.com/7271890/susan-…

I’m proud to welcome Dr. Vinay Prasad, MD, MPH, as the new head of FDA’s Center for Biologics Evaluation & Research. With 500+ peer-reviewed publications and two books, Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant

Vinay is a rare combination of scientist, clinician, and communicator. Many equate praise with agreement—but let me be clear: Vinay and I often disagree. My praise lies in his using evidence not to simplify but to provoke thoughtful deliberation. Through his work and friendship,

Congratulations Vinay Prasad MD MPH and U.S. FDA and Marty Makary MD, MPH If you care about evidence-based practice, there’s no better choice than VP. This is a win for US healthcare and a giant step forward in regaining lost trust We endorse Professor Prasad 👇🏻

statnews.com/2025/05/06/vin…

Last MPH epi methods class today. We ended with a reminder: Just because a public health policy feels good or sounds well-intentioned doesn’t mean it’s effective or even necessary. Evidence > vibes.

The new CBER director struck a humble, self-deprecating, and even earnest tone in his speech to FDA staff. trib.al/1ZecbfJ

New: AstraZeneca failed to convince a federal appeals court that the Medicare Drug Price Negotiation Program is unconstitutional, dealing another blow to the drug industry’s fight against the Biden-era plan. news.bloomberglaw.com/health-law-and…

From my 1st NRHA in 2011, to presenting every year since, receiving the 2017 outstanding student award & the 2025 researcher of the year award. Thank you NRHA for nurturing my National Rural Health Association research journey! Grateful 4 all USC Research #USCRHRC U of MN Rural Health Yale School of Public Health Emory University

Any sensible public health professional with common sense is able to, at least in hindsight, admit that schools should have reopened sooner. Mistakes were made and admitting them is how you make sure they aren’t made again.

Blue states tend to do better in K-12 education because they are wealthier and have higher rates of parents with tertiary education. But if you adjust for those ingrained advantages, blue state performance diminishes, and the south broadly emerges as leaders.

Loud claims are circulating that “no childhood vaccine was ever tested against placebo.” That is flat-out wrong. Here’s what the evidence actually shows. 🧵👇 1/

The Big Not-So-Beautiful Bill has officially passed both chambers. Despite a few conservative provisions, it explodes the deficit in the near term. This is Washington's MO: short-term politicking over long-term sustainability.

Happy birthday, America! 🦅🇺🇸

Effective workforce development and higher education policy recognizes an all of the above approach: R1, public regionals, community colleges, and trade and vocational schools. Don't fall for zero sum thinking. We need all pathways for citizens to flourish.

Huh. I wonder why?

What was controversial? The drug was never shown to work Peter Marks overruled decision despite ineffective evidence & a harm signal After 3 (or is it 4?) deaths fda pulled it Mainstream health news has really failed on this, over and over

Shame on Marty Makary. If Big Pharma can launder opposition research through Laura Loomer to get inconvenient people out of the way, Big Pharma is still running FDA.

Susan Monarez confirmed as Trump’s CDC director - via The Associated Press trib.al/XDcrYLQ